Viral Panel Comprehensive
Understand your immune system’s response to common and clinically significant viruses
The Viral Panel Comprehensive evaluates your body’s immune response to a group of important viruses, including herpesviruses (HSV, HHV-6, EBV), cytomegalovirus (CMV), measles, and varicella-zoster. These pathogens are widespread, and many people are exposed to them during childhood or adolescence. While most infections remain silent or mild, in some individuals they can contribute to chronic symptoms, immune dysregulation, or viral reactivation.
This panel measures both IgG (long-term immunity or past exposure) and IgM (recent or active immune response) antibodies. Together, these markers help identify whether your immune system is responding to a current infection, showing evidence of a past infection, or displaying patterns that may suggest viral reactivation.
What This Panel Helps You Understand
1. Past Exposure vs. Recent Infection
-
IgG antibodies indicate previous contact with a virus and long-term immune memory.
-
IgM antibodies can signal a more recent or active response.
This distinction is essential when evaluating symptoms such as fatigue, swollen lymph nodes, recurrent infections, or suspected viral reactivation.
2. Viral Reactivation Patterns
Some viruses—especially Epstein-Barr virus (EBV) and Human Herpesvirus-6 (HHV-6)—can remain dormant and reactivate under certain conditions. Reactivation may contribute to:
-
Chronic fatigue
-
Immune dysfunction
-
Autoimmune processes
-
Neurological symptoms
The panel includes markers that help identify possible reactivation, such as EBV Early Antigen or elevated IgM levels in the absence of an acute infection.
3. Immunity Status for Childhood Viruses
Markers for measles, varicella-zoster (chickenpox), and CMV help determine whether you have protective immunity or evidence of recent exposure. This is particularly useful for:
-
Children
-
Immunocompromised individuals
-
People evaluating vaccine immunity
-
Anyone with recurrent or unexplained viral symptoms
Who This Panel Is Helpful For
This panel is often used by clinicians when evaluating:
-
Persistent fatigue, flu-like symptoms, or unexplained malaise
-
Suspected EBV or HHV-6 involvement
-
Immune system dysregulation
-
Chronic inflammatory or autoimmune conditions
-
Recurrent viral infections
-
Immune status in children or adolescents
-
Follow-up after previous abnormal viral titers
What the Results Mean
Your report will show each viral marker with:
-
Your measured value
-
Reference ranges
-
Whether the result suggests past exposure, active infection, immunity, or reactivation patterns
This makes it easier to see how your immune system is interacting with each virus.
For example:
-
Negative IgG and IgM → No evidence of prior or current infection
-
Positive IgG, negative IgM → Past infection or immunity
-
Positive IgM → Recent or ongoing immune activity
-
EBV Early Antigen elevation → Possible reactivation
-
High HHV-6 IgM → Possible active or reactivated HHV-6 response
Why These Viruses Matter
Herpesviruses—such as EBV, CMV, HSV, and HHV-6—establish lifelong latency in the body. For most people this is harmless, but in others these viruses can influence:
-
Energy levels
-
Neurological function
-
Autoimmune activity
-
Susceptibility to other infections
Identifying which viruses the immune system is responding to can be an important step in understanding chronic or unexplained symptoms.
Takeaway
The Viral Panel Comprehensive provides a detailed look at how your immune system interacts with some of the most common and clinically relevant viruses. Whether you’re evaluating new symptoms, monitoring an ongoing condition, or simply confirming immune status, this panel helps provide clarity and direction for next steps.
Biomarkers in this category
13 biomarkers · optimal ranges shown
IgG to the Epstein–Barr Virus Early Antigen (EA) helps evaluate whether the virus may have been active or reactivated at some point. Early Antigen is a protein produced during the early phase of EBV replication. While most people only develop long-term antibodies to EBV’s Viral Capsid Antigen (VCA) and EBNA proteins, some individuals also develop EA IgG. EA IgG is sometimes used in conjunction with other EBV markers (VCA IgM, VCA IgG, EBNA IgG) to help understand patterns of: Past EBV infection Possible reactivation Chronic or recurrent EBV activity However, EA IgG alone does not diagnose acute EBV and often requires correlation with multiple markers. What It Means When Your EA IgG Result Is Within the Reference Range (Negative) A negative or normal IgG Early Antigen result means there is no evidence of immune activity directed at EBV’s Early Antigen. In practical terms, this indicates: No sign of recent EBV reactivation No indication of active viral replication No detectable EA-specific immune memory Because EA IgG is not always produced during routine EBV infections, many healthy individuals remain EA IgG negative even if they had mononucleosis or another EBV infection years earlier. A negative EA IgG result is therefore common and expected. When EA IgG is within the reference range: EBV is not actively replicating There is no laboratory support for ongoing or chronic EBV activity Past EBV exposure (if present) is considered stable and inactive This finding is especially meaningful when paired with negative EBV VCA IgM and negative or stable EBV IgG markers.
IgG EB Nuclear Antigen (EBNA IgG) measures long-term antibodies produced after infection with Epstein–Barr virus (EBV). EBNA IgG is a key marker because it typically appears later in the infection, often several months after the initial illness, and then remains detectable for life. For this reason, EBNA IgG is considered one of the most reliable indicators of past EBV infection. When positive, it helps confirm that someone has previously had EBV and has developed lasting immune memory to the virus. Clinicians often use EBNA IgG together with VCA IgG, VCA IgM, and Early Antigen (EA) to understand whether an infection is recent, past, or possibly reactivated. What It Means When Your EBNA IgG Result Is Within the Reference Range (Negative) A negative or normal EBNA IgG result means there is no detectable antibody response to the EBV Nuclear Antigen. This typically indicates: No evidence of a past EBV infection, or The infection was very recent, and EBNA antibodies have not yet appeared (less common), or Antibody levels are below the detection threshold of the test. Because EBNA IgG usually becomes positive months after infection and remains elevated for life, most adults who have ever had EBV will test positive. A negative result is therefore most common in: Young children Individuals who have never been exposed to EBV People being tested early in the course of a suspected new infection When EBNA IgG is within the reference range, and other EBV markers (VCA IgG, EA IgG, VCA IgM) are also negative, this strongly suggests no prior EBV infection.
IgG Epstein–Barr Virus Viral Capsid Antigen (EBV VCA IgG) measures long-term antibodies produced after infection with Epstein–Barr virus (EBV)—one of the most common human viruses. EBV typically causes infectious mononucleosis (“mono”) but can also produce very mild or even unnoticed infections, especially in children. VCA IgG antibodies usually appear a few weeks after infection and remain detectable for life. Because of this, EBV VCA IgG is a reliable marker for determining whether someone has been infected with EBV at any point in the past. This marker is most informative when combined with: EBV VCA IgM EBV Early Antigen (EA) EBV EBNA IgG Together, these help distinguish past infection, recent infection, and possible viral reactivation. What It Means When Your IgG EBV VCA Result Is Within the Reference Range (Negative) A negative or normal EBV VCA IgG result means there is no detectable evidence of a past EBV infection. Your immune system is not showing long-term antibodies to EBV’s Viral Capsid Antigen. When EBV VCA IgG falls within the reference range: You have not been previously infected with EBV, or Your antibody level is below the test’s detection limit, which is uncommon but possible in early infection. There is no indication of prior mononucleosis, nor of past EBV exposure. EBV is not currently active based on this antibody alone. Most adolescents and adults test positive for EBV IgG because past exposure is extremely common. A negative result simply means you have not developed lasting EBV antibodies yet.
IgG HHV-6 Herpe Type-6
IgM Cytomegalovirus (CMV) measures the level of IgM antibodies, which are the body’s first line of defense when encountering a virus. These antibodies typically appear during a new CMV infection or during viral reactivation. Because CMV is a common virus—often acquired in childhood—IgM testing helps determine whether your immune system is responding to a recent or ongoing infection. CMV IgM is often used together with CMV IgG, clinical symptoms, or PCR testing to clarify whether the infection is new, reactivating, or clinically significant. What It Means When Your IgM CMV Result Is Within the Reference Range (Negative) A negative or normal IgM CMV result means there is no evidence of a recent or active CMV infection at the time of testing. When IgM is within the reference range: Your immune system is not producing new CMV-specific IgM antibodies. There is no laboratory indication of a current or very recent infection. Viral reactivation is unlikely based on this marker alone. If you have CMV IgG antibodies, they reflect past exposure only, not new illness. A negative IgM result is reassuring and is the most common finding in healthy individuals.
IgM EB Nuclear Antigen (EBNA IgM) measures early antibodies directed against the Epstein–Barr Virus (EBV) Nuclear Antigen. Unlike other EBV markers, such as VCA IgM, EBNA IgM is not commonly produced and is generally not a standard marker of acute infection. When it does appear, it may indicate an early-phase immune response, but it is less specific and less commonly used in clinical decision-making. Because EBNA proteins are expressed later in the EBV life cycle, IgM antibodies to EBNA are rarely detected during typical EBV infections. For this reason, clinicians rely more heavily on VCA IgM, VCA IgG, EBNA IgG, and Early Antigen when evaluating EBV activity. EBNA IgM can sometimes be included in extended EBV panels to help rule out atypical or early immune responses. What It Means When Your EBNA IgM Result Is Within the Reference Range (Negative) A negative or normal EBNA IgM result means there is no evidence of a recent or acute immune response to the EBV Nuclear Antigen. In practical terms, this indicates: Your immune system is not producing early-phase EBNA-specific IgM antibodies. There is no laboratory support for an active or newly developing EBV infection based on this marker. This result is consistent with the vast majority of healthy individuals, as EBNA IgM is typically not elevated even during routine EBV infections. When EBNA IgM is within the reference range: EBV infection is unlikely to be recent. If other EBV markers (VCA IgM, EA IgG) are also negative, it supports the conclusion that EBV is not active. Past infection—if present—would be reflected in EBNA IgG, not in this marker. A negative EBNA IgM result is expected and reassuring, especially in the absence of symptoms suggestive of acute mononucleosis.
IgM Epstein–Barr Virus Viral Capsid Antigen (EBV VCA IgM) measures early antibodies produced by the immune system during a new or recent Epstein–Barr virus infection. EBV is a common virus best known for causing infectious mononucleosis (“mono”), especially in adolescents and young adults. VCA IgM antibodies are typically: Detectable during the acute phase of infection Present for only a short period (usually several weeks) Used to help identify whether symptoms—such as fatigue, swollen lymph nodes, sore throat, or fever—are related to a current EBV infection Because IgM rises quickly and declines relatively fast, it is a key marker for determining if EBV infection is occurring now or very recently. What It Means When Your IgM EBV VCA Result Is Within the Reference Range (Negative) A negative or normal IgM EBV VCA result means there is no evidence of a recent or active Epstein–Barr virus infection at the time of testing. When this marker is within the reference range: Your immune system is not producing early, active-phase EBV antibodies. There is no laboratory indication of a current mono-like infection. Any past exposure you may have had is not recent—and would instead be reflected in EBV IgG markers, not IgM. This result is reassuring and is the most common finding in individuals without active symptoms. A negative IgM result is especially helpful when interpreting the rest of the EBV panel; it supports the conclusion that EBV is not driving current symptoms. If symptoms persist, clinicians may look at additional markers—such as EBV EBNA IgG, EBV VCA IgG, or Early Antigen (EA)—to build a more complete picture.